Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Paula Ragan, Ph.D., is the CEO of X4 Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for rare and serious diseases. Dr. Ragans leadership is characterized by a commitment to advancing innovative drug development and addressing significant medical needs. With extensive experience in biotechnology and clinical development, she has been instrumental in guiding X4 Pharmaceuticals through key stages of research and clinical trials. Her vision includes leveraging cutting-edge science to develop transformative therapies and improve patient outcomes. Under her guidance, X4 Pharmaceuticals continues to make significant progress in advancing its therapeutic pipeline and contributing to the field of rare disease treatments.
